Pratley RE, Aroda VR, Lingvay I, Ldemann J, Andreassen C, Navarria A et al (2018) Semaglutide versus dulaglutide once weekly in patients with type 2 diabetes (SUSTAIN 7): a randomised, open-label, phase 3b trial
As a result, the manufacturers and developers frequently have to undergo case-by-case consultation with these authorities in the course of preclinical development and clinical trial planning
Combined with therapy, lifestyle interventions, and attention to inflammation and other biological factors, even modest doses can produce meaningful results with minimal side effects
Nausea, diarrhea, and digestive discomfort occur somewhat more frequently with tirzepatide than with semaglutide
How clinicians reduce side effects: titration and the habits that actually work There's no single trick that makes side effects disappear
How Foundayo Weight Loss Results Compare With the Wegovy Pill By the end of the study, people on the highest dose lost an average of about 27 pounds (12.4 percent of their starting body weight), compared with average weight loss of just 2.2 pounds with the placebo
